Beth Dean

Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean.

Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean.

Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean.

Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean.